| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.47 | 0.09 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |